Oman Pharma Growth Mission 2026
  Website Enquiry Details From '.$fname.'
  Company Name '.$fname.'
  Company Person '.$cname.'
  Designation '.$designation.'
  Country '.$country.'
  E-Mail '.$email.'
  Mobile '.$phone.'
  Website '.$website.'
  Sector '.$sector.'
  Area of Interest '.$areainterest.'
  Meeting Objective '.$meeting.'
  Where did you hear of us '.$how.'
  Warm Regards,  
   Oman Pharma Growth Mission 2026  
'; $subject="Website Enquiry Details From ".$fname; $to="marketinggroup@duqm.gov.om"; // Additional headers $headers = 'MIME-Version: 1.0' . "\r\n"; $headers .= 'Content-type: text/html; charset=iso-8859-1' . "\r\n"; $headers .= 'Sender: ' . "\r\n"; $headers .= 'From: '.$fname.' ' . "\r\n"; $headers .= 'Reply-To: '.$fname.' <'.$email.'>' . "\r\n"; $res1=mail($to , $subject, $messages, $headers, '-fnoreply@opgm-opaz.com'); if($res1) { $msg="Thank you for contacting Oman Pharma Growth Mission 2026, we will get back to you shortly."; header('location:index.php?msg='.$msg); } else { $errors = "Error Occured.Try Once Again"; } } // echo $messages; ?> Oman Pharma Growth Mission 2026
Oman Pharma Growth Mission 2026

Oman Pharma Growth Mission 2026 | Driven by OPAZ

OPGM 2026 is Oman’s focused pharma and healthcare business mission to India, led by OPAZ. OPGM brings Oman’s Investment, Free Zone, Export, Industrial and Healthcare related Stakeholders to New Delhi to meet Indian Companies, Suppliers, Investors, Regulators, Policy Bodies and Sector Partners.

OPGM 2026 focus is simple:

Convert the India - Oman CEPA Corridor into practical business conversations across Trade, Supply, Capital, Technology, Manufacturing and FDI.

Public Authority for Special Economic Zones and Free Zones

01

Why Pharma?

Pharma is emerging as a strategic opportunity within Oman’s move towards high-value manufacturing and integrated healthcare industries. Investment opportunities span the value chain, including:

Generic pharmaceuticals API production Vaccines & biopharmaceuticals Research laboratories Medical equipment Surgical & laboratory instruments Digital health Smart health monitoring

OPGM begins with pharma, with the potential to build future sector-growth missions for Oman.

02

India - Oman CEPA

The Comprehensive Economic Partnership Agreement (CEPA) between India and Oman creates a stronger framework for expanding bilateral trade and investment.

OPAZ’s 2026–2030 Five-Year Plan identifies the activation of CEPA with India, alongside increasing investment flows, developing supply chains, facilitating investor partnerships and connecting businesses to global markets.

For Indian pharmaceutical companies, this creates a stronger case to look beyond exporting into Oman and consider opportunities in manufacturing, localisation, supply-chain integration and regional market expansion.

Supply to Oman | Establish in Oman | Serve larger markets from Oman

What Oman Provides it's Investors

Oman provides pharmaceutical investors with an integrated logistics environment designed to support the movement of products across regional and international markets.

Environmental & Sustainability Infrastructure

Water & Resource Management

Water desalination and treatment support pharmaceutical manufacturing.

Environmental Compliance

Environmental permitting covers air, water and soil quality, waste and chemical management, emissions control and monitoring.

Smart Environmental Monitoring

Digital systems, monitoring stations, drones and sensors support environmental oversight.

Clean & Sustainable Industry

Renewable energy, green hydrogen, carbon capture, recycling and resource-efficiency initiatives support the transition towards a low-carbon economy.

Integrated Environmental Coordination

Permitting, monitoring, data exchange and harmonised requirements help streamline environmental compliance across economic, free and industrial zones.

Import & Export Infrastructure in Oman

01

Strategic seaports such as Port of Duqm and Sohar Port, providing access to international shipping routes and global markets.

02

Integrated industrial and logistics hubs, particularly Sohar Free Zone, which combines advanced infrastructure, logistics services and proximity to global maritime transport networks.

03

Air connectivity through Muscat Airport Free Zone, supporting faster cargo handling and reduced transit times for products requiring rapid supply chains, including pharmaceuticals.

04

Multimodal logistics, integrating air, sea and land transportation with economic and free zones through the Asyad ecosystem.

05

Specialised storage infrastructure, including ready-built dry and refrigerated storage facilities and opportunities for pharmaceutical warehousing.

06

Accelerated customs clearance and simplified customs procedures to facilitate the movement of goods.

Benefits and Incentives

100% foreign ownership

Tax exemptions for up to 30 years

No minimum capital requirement

Usufruct agreements of up to 50 years, renewable

Customs exemptions on raw materials and equipment

Up to 30% of the Ministry of Health's requirement for the product

30% price preference for qualifying full manufacturing in government tenders

20% price preference for secondary packaging

Freedom to transact in all currencies

Investor Resources & E-Services

Access Oman’s digital platforms designed to help investors explore opportunities, access information and complete services related to investment and economic zones.

OMAP – Oman’s Investment & Opportunity Platform

Explore investment opportunities and relevant information through Oman’s digital investment platform.

Visit OMAP

OPAZ E-Services Portal

Access OPAZ’s digital services for economic zones, free zones and industrial cities.

Visit OPAZ E-Services Portal

Pharmaceutical Success Stories from Oman

01

Salalah Free Zone

With over USD 600 million in pharmaceutical investments, Salalah Free Zone is home to major projects including Philex Pharmaceuticals, Dhofar Pharmaceutical Industries Company SAOG, the International Pharmaceutical Complex, and Oman Pharmaceutical Products (OPP).

02

Philex Pharmaceuticals

A USD 150 million investment with an annual production capacity of 1 billion tablets and capsules.

03

National Pharmaceutical Industries (NPI)

Exports pharmaceutical products to more than 50 countries worldwide.

04

Dhofar Pharmaceutical Industries Company SAOG

Opened a new manufacturing facility in Raysut in 2024.

05

Menagen Pharmaceutical Industries

Specialises in oncology and rare-disease treatments and was established in 2024.

Your Opportunity

Meet Oman if you are looking to:

Supply to Oman Partner with Oman Invest in Oman Manufacture in Oman

Use Oman to serve GCC, Africa, Middle East and wider markets

Share your profile and objectives. The OPGM team will review your request and connect you with the relevant Oman delegation.

Request the OPGM Brochure
Request the OPGM Brochure

Request the OPGM Brochure

Understand the mission, the delegation, the opportunity areas and how your company can engage with Oman at Bharat Health Global Expo 2026.

Request the OPGM Brochure Request Brochure
Request a Meeting with Oman

Request a Meeting with Oman

Submit your company profile and business objective. The OPGM team will review your interest and route your request to the right Oman stakeholder.

Request a Meeting with OmanRequest Meeting